Internet-Based Drug Prevention Education for College Students

大学生网络毒品预防教育

基本信息

批准号：
7163417
负责人：
Emil J. Chiauzzi
金额：
$ 41.33万
依托单位：
INFLEXXION, INC.
依托单位国家：
美国
项目类别：
财政年份：
2004
资助国家：
美国
起止时间：
2004-08-05 至 2009-02-28
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/7163417
关键词：
Address Administrator Advisory Committees Age Alcohols Amphetamines Attention Behavior Caring Control Groups Coping Skills Development Dextroamphetamine Drug Addiction Drug Interactions Drug Prescriptions Drug usage Education Ensure Feedback Fostering Frequencies Health Health Knowledge, Attitudes, Practice Health Professional Hydrocodone Illicit Drugs Individual Internet Knowledge Marijuana Marketing Medical Methods Mission Motivation Multimedia National Institute of Drug Abuse Numbers Opioid Overdose Oxycodone Perception Pharmaceutical Preparations Phase Prevalence Prevention Prevention education Prevention intervention Prevention program Production Public Health Randomized Controlled Trials Range Rate Reporting Research Research Personnel Resources Risk Risk Assessment Risk Behaviors Schools Science Secondary Prevention Self Efficacy Site Small Business Funding Mechanisms Small Business Innovation Research Grant Standards of Weights and Measures Stream Stress Students Surveys Technology Testing Tobacco Work Youth aged alcohol and other drug animation base college college drinking commercialization concept desire drug abuse education drug abuse prevention experience high school neglect nutrition peer prescription document prescription drug abuse prescription procedure prevent programs psychologic response satisfaction self help skills social tool university student usability

项目摘要

DESCRIPTION (provided by applicant): This application proposes development and testing of an interactive, online drug use prevention program for college students, MyStudentBody-Drugs (MSB-Drugs). Geared toward primary and secondary prevention, MSB-Drugs will promote motivation to prevention initiation of, or reduce, drug use and associated risk behaviors. Compared to alcohol, drug use prevention is neglected on campuses, despite the prevalence of use and significant consequences. Marijuana is the most widely used illicit drug, followed by non-medical use of prescription drugs, including stimulants (dextroamphetamine, methyphenidate) and opioids (oxycodone, hydrocodone). In 2003, roughly 10 percent of high school seniors reported non- medical use of hydrocodone, making it the third most abused substance for this group, after marijuana and amphetamines. From 2002 to 2003, abuse of oxycodone increased by nearly 40 percent among college- aged youth. Mixing prescription drugs with other drugs, such as alcohol, further increases risk for drug interactions and overdose. The public health need for easily accessible and effective drug prevention for college students is clear. Recent NIDA initiatives recognize this need (Prescription Drug Abuse, PA-01-110; Volkow, 2005). MSB-Drugs will use technology and rich media to incorporate key evidence-based prevention features, including personal risk assessments with tailored feedback to promote motivation, relevant education about different drugs and addiction to foster accurate risk appraisals, and skill-building activities to promote refusal and coping skills and self-efficacy. Phase I involved proof of concept research to demonstrate product feasibility. Phase II will involve production and usability testing of a fully operational MSB-Drugs website, and a randomized, controlled trial to assess program efficacy for influencing drug- related knowledge, attitudes, and behaviors.

描述（由申请人提供）：本申请建议开发和测试针对大学生的交互式在线药物使用预防计划 MyStudentBody-Drugs (MSB-Drugs)。 MSB-Drugs 针对一级和二级预防，将促进预防或减少药物使用和相关危险行为的动机。与酗酒相比，尽管吸毒现象普遍且后果严重，但校园吸毒预防却被忽视。大麻是使用最广泛的非法药物，其次是非医疗用途的处方药，包括兴奋剂（右旋苯丙胺、哌醋甲酯）和阿片类药物（羟考酮、氢可酮）。 2003 年，约 10% 的高中生报告称氢可酮非医疗用途，使其成为该群体中第三大滥用的物质，仅次于大麻和安非他明。从 2002 年到 2003 年，大学生中羟考酮的滥用增加了近 40%。将处方药与其他药物（例如酒精）混合，会进一步增加药物相互作用和用药过量的风险。公共卫生对大学生易于获得且有效的毒品预防的需求是显而易见的。最近的 NIDA 举措认识到了这一需求（处方药滥用，PA-01-110；Volkow，2005）。 MSB-Drugs 将利用技术和富媒体整合关键的循证预防功能，包括个人风险评估和定制反馈以促进动机、有关不同药物和成瘾的相关教育以促进准确的风险评估，以及技能建设活动以促进拒绝以及应对技巧和自我效能。第一阶段涉及概念验证研究以证明产品的可行性。第二阶段将涉及全面运作的 MSB-Drugs 网站的生产和可用性测试，以及一项随机对照试验，以评估项目对影响药物相关知识、态度和行为的功效。